(Q33385960)

26 July 2017

title

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes (English)

1 reference

26 July 2017

1 reference

Daniel Chan

1

1 reference

26 July 2017

Wee-Lee Yeo

2

1 reference

26 July 2017

Maricel Tiemsim Cordero

3

1 reference

26 July 2017

Chiung-Ing Wong

4

1 reference

26 July 2017

Benjamin Chuah

5

1 reference

26 July 2017

Ross Soo

6

1 reference

26 July 2017

Sing-Huang Tan

7

1 reference

26 July 2017

Siew-Eng Lim

8

1 reference

26 July 2017

Boon-Cher Goh

9

1 reference

26 July 2017

Soo-Chin Lee

10

1 reference

26 July 2017

publication date

25 August 2009

1 reference

Investigational New Drugs

26 July 2017

published in

1 reference

26 July 2017

volume

28

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

859-865

1 reference

Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer

26 July 2017

cites work

1 reference

12 December 2020

Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

1 reference

12 December 2020

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

1 reference

12 December 2020

Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer

1 reference

12 December 2020

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial

1 reference

12 December 2020

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

12 December 2020

High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer

1 reference

12 December 2020

Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer

1 reference

12 December 2020

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.

1 reference

12 December 2020

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial

1 reference

12 December 2020

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

1 reference

12 December 2020

Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

1 reference

12 December 2020

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

1 reference

12 December 2020

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer

1 reference

12 December 2020

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast

1 reference

12 December 2020

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

12 December 2020

Interaction between cisplatin and gemcitabine in vitro and in vivo.

1 reference

12 December 2020

Phase II study of gemcitabine plus cisplatin in metastatic breast cancer

1 reference

12 December 2020

Combination chemotherapy studies with gemcitabine

1 reference

12 December 2020

Single-agent gemcitabine is active in previously treated metastatic breast cancer

1 reference

12 December 2020

10.1007/S10637-009-9305-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1047145900

0 references

Fatcat ID

release_6tkn34wycjho3hvn4avnudy2xq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6tkn34wycjho3hvn4avnudy2xq

24 November 2022

mapped directly with Wikidata item

1 reference